Personalized mRNA Vaccines Will Revolutionize Cancer Treatment—If Federal Funding Cuts Don’t Doom Them

Vaccines based on mRNA can be tailored to target a cancer patient’s unique tumor mutations. But crumbling support for cancer and mRNA vaccine research has endangered this promising therapy